Do thiazolidinediones and metformin reduce mortality in older patients with diabetes and heart failure?
Thiazolidinediones and metformin may be safe and potentially beneficial in older patients with concurrent diabetes and heart failure, though randomized trials are needed to confirm.
This observational study suggests that thiazolidinediones and metformin are not associated with increased mortality and may improve outcomes in older patients with diabetes and heart failure. Randomized trials are warranted to corroborate these findings.
Masoudi et al. (Mon,) studied this question.